Position history for BlackRock, Inc.'s holdings in AMYLYX PHARMACEUTICALS INC
BlackRock, Inc. holds 9.1M shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $109.4M as of 2025-Q4. The position was increased (++26.8% shares). AMLX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$109.4M
Current Shares
9.1M
Total Value Change
+$100.8M
Total Shares Change
+6.8M
Other major holders of AMLX: Kestra Advisory Services, LLC, FMR LLC, VIKING GLOBAL INVESTORS LP
Increased |
| 9.1M |
+26.8% |
| $109.4M |
| 0.0% |
| $12.00 |
37 |
| 2025-Q3 | Increased | 7.1M | +29.6% | $97M | 0.0% | $14.90 | 38 |
| 2025-Q2 | Increased | 5.5M | +130.8% | $35.3M | 0.0% | $6.33 | 47 |
| 2025-Q1 | Increased | 2.4M | +4.8% | $8.5M | 0.0% | $3.66 | 29 |
| 2024-Q4 | New | 2.3M | - | $8.6M | 0.0% | $3.84 | 38 |